NEW YORK (GenomeWeb News) – MDxHealth today said that its revenues for the first half of 2013 doubled year over year.

For the six months ended June 30, total revenues reached €3.0 ($4.0 million), up from €1.5 million in the first half of 2012. All revenues came from commercial operations as MDxHealth received no government grants, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.